(*) CA Approval Date: 2016. 11.21.
(*) EU Approval Date: 2012.
>Ulipristal Acetate Tablets
Company/Licensee EU
Company/Licensee NA
Company/Licensor
Patent>Assignee; Claims; No.; Etc.
Patent>Expiration: 2029. 02.20.
Patent>UpDate: 2018. 08.28.
Risk of Liver Injury Web-Site
TradeMark EU
TradeMark NA